{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:48:42Z","timestamp":1790873322958,"version":"4.1.0"},"reference-count":214,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.canlet.2010.08.019","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T16:15:59Z","timestamp":1302884159000},"page":"263-278","source":"Crossref","is-referenced-by-count":43,"title":["Infectious agents in human cancers: Lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV"],"prefix":"10.1016","volume":"305","author":[{"given":"Graham S.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Blackbourn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2010.08.019_b0005","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1128\/JVI.74.10.4919-4928.2000","article-title":"Characterization of two divergent lineages of macaque rhadinoviruses related to Kaposi\u2019s sarcoma-associated herpesvirus","volume":"74","author":"Schultz","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0010","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1128\/JVI.74.3.1572-1577.2000","article-title":"Two distinct gamma-2 herpesviruses in African green monkeys: a second gamma-2 herpesvirus lineage among old world primates?","volume":"74","author":"Greensill","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0015","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt\u2019s Lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2010.08.019_b1075","unstructured":"A.B. Rickinson, E. Kieff, Epstein-Barr virus, in: Fields Virology, Lippincott Williams & Wilkins, New York, 2007, pp. 2655\u20132670."},{"key":"10.1016\/j.canlet.2010.08.019_b0025","doi-asserted-by":"crossref","first-page":"14935","DOI":"10.1073\/pnas.0509988103","article-title":"Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells","volume":"103","author":"Kelly","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2010.08.019_b0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","article-title":"Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation","volume":"345","author":"Rooney","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2010.08.019_b0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/asheducation-2007.1.277","article-title":"Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy","author":"Kelly","year":"2007","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.canlet.2010.08.019_b0040","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/nm758","article-title":"Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2","volume":"8","author":"Kelly","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2010.08.019_b0045","doi-asserted-by":"crossref","first-page":"e1000341","DOI":"10.1371\/journal.ppat.1000341","article-title":"An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp\/BHRF1 link","volume":"5","author":"Kelly","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.canlet.2010.08.019_b0050","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/(SICI)1097-0215(19961104)68:3<285::AID-IJC3>3.0.CO;2-Y","article-title":"Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin\u2019s disease","volume":"68","author":"Chiang","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2010.08.019_b0055","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2010.08.019_b0060","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2010.08.019_b0065","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1126\/science.8438152","article-title":"Cloning the differences between two complex genomes","volume":"259","author":"Lisitsyn","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.canlet.2010.08.019_b0070","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi\u2019s sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.canlet.2010.08.019_b1080","doi-asserted-by":"crossref","first-page":"14862","DOI":"10.1073\/pnas.93.25.14862","article-title":"Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)","volume":"93","author":"Russo","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2010.08.019_b0080","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1099\/vir.0.81919-0","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus immune modulation: an overview","volume":"87","author":"Rezaee","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0085","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1086\/517356","article-title":"Human herpesvirus 8 detection in nasal secretions and saliva","volume":"177","author":"Blackbourn","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2010.08.019_b0090","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJM200011093431904","article-title":"Mucosal shedding of Human Herpesvirus 8 in MEN","volume":"343","author":"Pauk","year":"2000","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.canlet.2010.08.019_b0095","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1126\/science.7725108","article-title":"Herpes-like sequences in HIV-infected and uninfected Kaposi\u2019s sarcoma patients","volume":"268","author":"Ambroziak","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.canlet.2010.08.019_b0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00002030-199702000-00016","article-title":"Human herpesvirus 8 in semen and prostate","volume":"11","author":"Blackbourn","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2010.08.019_b0105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1086\/314570","article-title":"Increased human herpesvirus 8 seroprevalence in young homosexual men who have multiple sex contacts with different partners","volume":"179","author":"Blackbourn","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2010.08.019_b0110","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1086\/517429","article-title":"High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi\u2019s sarcoma from Sardinia","volume":"177","author":"Angeloni","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2010.08.019_b0115","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nm0896-925","article-title":"KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi\u2019s sarcoma","volume":"2","author":"Gao","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2010.08.019_b0120","doi-asserted-by":"crossref","unstructured":"D.H. Kedes, E. Operskalski, M. Busch, R. Kohn, J. Flood, D. Ganem, The seroepidemiology of human herpesvirus 8 (Kaposi\u2019s sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission [published erratum appears in Nat. Med. 2(9) (1996 September) 1041], Nat. Med. 2 (1996) 918\u2013924 (see comments).","DOI":"10.1038\/nm0896-918"},{"key":"10.1016\/j.canlet.2010.08.019_b0125","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0140-6736(96)03240-0","article-title":"Antibodies to human herpesvirus type 8 in the general population and in Kaposi\u2019s sarcoma patients","volume":"348","author":"Lennette","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2010.08.019_b0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/10408360590913524","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus: clinical diagnostic and epidemiological aspects","volume":"42","author":"Cohen","year":"2005","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.canlet.2010.08.019_b0135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens \u2013 part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2010.08.019_b0140","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/nm1295-1274","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus infects endothelial and spindle cells","volume":"1","author":"Boshoff","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2010.08.019_b0145","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1097\/QAD.0b013e3283031a9f","article-title":"Risk factors in the development of Kaposi\u2019s sarcoma","volume":"22","author":"Colman","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2010.08.019_b0150","doi-asserted-by":"crossref","first-page":"F35","DOI":"10.1097\/00002030-199705000-00001","article-title":"Visualization of human herpesvirus type 8 in Kaposi\u2019s sarcoma by light and transmission electron microscopy","volume":"11","author":"Orenstein","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2010.08.019_b0155","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/jnci\/49.6.1509","article-title":"Herpes-type virus particles in tissue culture of Kaposi\u2019s sarcoma from different geographic regions","volume":"49","author":"Giraldo","year":"1972","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2010.08.019_b0160","first-page":"169","article-title":"Cytomegalovirus angiomatosis and Kaposi\u2019s sarcoma: new observations of a debated relationship","volume":"5","author":"Ioachim","year":"1992","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.canlet.2010.08.019_b0165","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0140-6736(83)90062-4","article-title":"Acquired immunodeficiency syndrome is an opportunistic infection and Kaposi\u2019s sarcoma results from secondary immune stimulation","volume":"2","author":"Levy","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2010.08.019_b0170","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.3262925","article-title":"Kaposi\u2019s sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells","volume":"242","author":"Nakamura","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.canlet.2010.08.019_b0175","first-page":"2007","article-title":"Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi\u2019s sarcoma: a combined in vitro and in vivo analysis","volume":"10","author":"Sturzl","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2010.08.019_b0180","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1126\/science.282.5395.1837","article-title":"The enigmas of Kaposi\u2019s sarcoma","volume":"282","author":"Gallo","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.canlet.2010.08.019_b0185","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1073\/pnas.89.15.7046","article-title":"Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance","volume":"89","author":"Sturzl","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2010.08.019_b0190","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1126\/science.274.5293.1739","article-title":"Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV","volume":"274","author":"Moore","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.canlet.2010.08.019_b0195","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1128\/JVI.71.1.839-842.1997","article-title":"Human herpesvirus 8 encodes a homolog of interleukin-6","volume":"71","author":"Neipel","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0200","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nm0397-287","article-title":"Kaposi\u2019s sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6","volume":"3","author":"Nicholas","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2010.08.019_b0205","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1182\/blood.V91.6.1858","article-title":"Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells","volume":"91","author":"Burger","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b0210","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1128\/JVI.71.3.1963-1974.1997","article-title":"A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins","volume":"71","author":"Nicholas","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0215","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1128\/JVI.75.2.891-902.2001","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays","volume":"75","author":"Jenner","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0220","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1128\/JVI.75.10.4843-4853.2001","article-title":"Transcription program of human herpesvirus 8 (kaposi\u2019s sarcoma-associated herpesvirus)","volume":"75","author":"Paulose-Murphy","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0225","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.191.3.445","article-title":"Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi\u2019s sarcoma","volume":"191","author":"Yang","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2010.08.019_b0230","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1099\/vir.0.19015-0","article-title":"Transcription mapping of human herpesvirus 8 genes encoding viral interferon regulatory factors","volume":"84","author":"Cunningham","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0235","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.96.8.4546","article-title":"Distribution of human herpesvirus-8 latently infected cells in Kaposi\u2019s sarcoma, multicentric Castleman\u2019s disease, and primary effusion lymphoma","volume":"96","author":"Dupin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2010.08.019_b0240","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1128\/JVI.71.1.715-719.1997","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells","volume":"71","author":"Staskus","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0245","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199904083401402","volume":"340","author":"Martin","year":"1999","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.canlet.2010.08.019_b0250","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s004030050215","article-title":"Characterization of in vitro culture of HIV-negative Kaposi\u2019s sarcoma-derived cells, In vitro responses to alfa interferon","volume":"289","author":"Lebbe","year":"1997","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.canlet.2010.08.019_b0255","first-page":"2009","article-title":"Human herpesvirus 8 (Kaposi\u2019s sarcoma-associated herpesvirus) DNA in Kaposi\u2019s sarcoma lesions, AIDS Kaposi\u2019s sarcoma cell lines, endothelial Kaposi\u2019s sarcoma simulators, and the skin of immunosuppressed patients","volume":"148","author":"Dictor","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2010.08.019_b0260","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm0396-342","article-title":"Lytic growth of Kaposi\u2019s sarcoma-associated herpesvirus (human herpesvirus 8) in culture","volume":"2","author":"Renne","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2010.08.019_b0265","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1126\/science.2459779","article-title":"Angiogenic properties of Kaposi\u2019s sarcoma-derived cells after long-term culture in vitro","volume":"242","author":"Salahuddin","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.canlet.2010.08.019_b0270","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.2643161","article-title":"AIDS-Kaposi\u2019s sarcoma-derived cells express cytokines with autocrine and paracrine growth effects","volume":"243","author":"Ensoli","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.canlet.2010.08.019_b0275","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI117521","article-title":"Block of AIDS-Kaposi\u2019s sarcoma (KS) cell growth angiogenesis and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor, A novel strategy for the therapy of KS","volume":"94","author":"Ensoli","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2010.08.019_b0280","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1172\/JCI117849","article-title":"Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi\u2019s sarcoma spindle cells","volume":"95","author":"Fiorelli","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2010.08.019_b0285","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00002030-199405000-00002","article-title":"Characterization of a human Kaposi\u2019s sarcoma cell line that induces angiogenic tumors in animals","volume":"8","author":"Herndier","year":"1994","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2010.08.019_b0290","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/jnci\/87.13.974","article-title":"Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi\u2019s sarcoma","volume":"87","author":"Lunardi-Iskandar","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2010.08.019_b0295","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00042560-199610010-00011","article-title":"Absence of human herpesvirus 8 DNA sequences in neoplastic Kaposi\u2019s sarcoma cell lines","volume":"13","author":"Flamand","year":"1996","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.canlet.2010.08.019_b0300","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/29093","article-title":"Transformation of primary human endothelial cells by Kaposi\u2019s sarcoma-associated herpesvirus","volume":"394","author":"Flore","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2010.08.019_b0305","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1128\/JVI.73.8.6892-6902.1999","article-title":"Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8","volume":"73","author":"Moses","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0310","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1128\/JVI.75.12.5614-5626.2001","article-title":"Spindle cell conversion by Kaposi\u2019s sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures","volume":"75","author":"Ciufo","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0315","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1128\/JVI.80.10.4833-4846.2006","article-title":"Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi\u2019s sarcoma-associated herpesvirus latency in vitro and in vivo","volume":"80","author":"An","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b1085","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/34193","article-title":"G-protein-coupled receptor of Kaposi\u2019s sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator","volume":"391","author":"Bais","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2010.08.019_b0325","doi-asserted-by":"crossref","unstructured":"S.J. Gao, C. Boshoff, S. Jayachandra, R.A. Weiss, Y. Chang, P.S. Moore, KSHV ORF K9 (vIRF) is an Oncogene Which Inhibits the Interferon Signaling Pathway in Oncogene, 1997, pp. 1979\u20131985.","DOI":"10.1038\/sj.onc.1201571"},{"key":"10.1016\/j.canlet.2010.08.019_b0330","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1128\/JVI.72.6.4980-4988.1998","article-title":"Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi\u2019s sarcoma-associated herpesvirus) transforming gene","volume":"72","author":"Muralidhar","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0335","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nm0498-435","article-title":"Deregulation of cell growth by the K1 gene of Kaposi\u2019s sarcoma-associated herpesvirus","volume":"4","author":"Lee","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2010.08.019_b0340","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/00002030-199209000-00001","article-title":"Cellular and molecular features of HIV-associated Kaposi\u2019s sarcoma","volume":"6","author":"Roth","year":"1992","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2010.08.019_b0345","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1158\/0008-5472.CAN-03-2767","article-title":"Host gene induction and transcriptional reprogramming in Kaposi\u2019s sarcoma-associated herpesvirus (KSHV\/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection","volume":"64","author":"Naranatt","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2010.08.019_b0350","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/ng1384","article-title":"Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma","volume":"36","author":"Wang","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2010.08.019_b0355","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/ng1383","article-title":"Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus","volume":"36","author":"Hong","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2010.08.019_b0360","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.virol.2004.07.008","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation","volume":"328","author":"Carroll","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.canlet.2010.08.019_b0365","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas","volume":"332","author":"Cesarman","year":"1995","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.canlet.2010.08.019_b0370","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","article-title":"Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi\u2019s sarcoma-associated herpes virus","volume":"88","author":"Nador","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b0375","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/CMR.15.3.439-464.2002","article-title":"Spectrum of Kaposi\u2019s sarcoma-associated herpesvirus, or human herpesvirus, 8 diseases","volume":"15","author":"Ablashi","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.canlet.2010.08.019_b0380","doi-asserted-by":"crossref","first-page":"10399","DOI":"10.1073\/pnas.1630810100","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile","volume":"100","author":"Jenner","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2010.08.019_b0385","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1056\/NEJM199601253340417","article-title":"Body-cavity-based lymphoma in an HIV-seronegative patient without Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences","volume":"334","author":"Hermine","year":"1996","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.canlet.2010.08.019_b0390","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood.V86.7.2708.2708","article-title":"In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi\u2019s sarcoma-associated herpesvirus-like (KSHV) DNA sequences","volume":"86","author":"Cesarman","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b0395","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood-2008-09-180315","article-title":"HIV-associated lymphomas and gamma-herpesviruses","volume":"113","author":"Carbone","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b0400","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/02841860410002752","article-title":"Fifty years of multicentric Castleman\u2019s disease","volume":"43","author":"Waterston","year":"2004","journal-title":"Acta Oncol."},{"key":"10.1016\/j.canlet.2010.08.019_b0405","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman\u2019s disease","volume":"86","author":"Soulier","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b0410","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/annonc\/mdn697","article-title":"The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman\u2019s disease","volume":"20","author":"Powles","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2010.08.019_b0415","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.1128\/JVI.72.10.8309-8315.1998","article-title":"A cluster of latently expressed genes in Kaposi\u2019s sarcoma-associated herpesvirus","volume":"72","author":"Dittmer","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0420","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/viro.1999.9672","article-title":"Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line","volume":"257","author":"Talbot","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.canlet.2010.08.019_b0425","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1128\/JVI.73.7.5722-5730.1999","article-title":"A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi\u2019s sarcoma- associated herpesvirus","volume":"73","author":"Sadler","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0430","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/JVI.75.1.429-438.2001","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53","volume":"75","author":"Rivas","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0435","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1182\/blood.V90.3.1186","article-title":"Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi\u2019s sarcoma-associated herpesvirus\/human herpesvirus-8","volume":"90","author":"Horenstein","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b0440","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1086\/314956","article-title":"Heterogeneity of viral IL-6 expression in HHV-8-associated diseases","volume":"180","author":"Cannon","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2010.08.019_b0445","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1128\/JVI.02723-09","article-title":"Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi\u2019s sarcoma-associated herpesvirus","volume":"84","author":"Chandriani","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0450","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1172\/JCI200417803","article-title":"Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis","volume":"113","author":"Grundhoff","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2010.08.019_b1090","doi-asserted-by":"crossref","first-page":"e1000935","DOI":"10.1371\/journal.ppat.1000935","article-title":"The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes","volume":"6","author":"Gunther","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.canlet.2010.08.019_b0460","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.tim.2009.09.002","article-title":"Role of virus-encoded microRNAs in herpesvirus biology","volume":"17","author":"Boss","year":"2009","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.canlet.2010.08.019_b0465","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng.266","article-title":"Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs","volume":"41","author":"Ziegelbauer","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2010.08.019_b0470","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nature05992","article-title":"A viral microRNA functions as an orthologue of cellular miR-155","volume":"450","author":"Gottwein","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2010.08.019_b0475","doi-asserted-by":"crossref","first-page":"12836","DOI":"10.1128\/JVI.01804-07","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus encodes an ortholog of miR-155","volume":"81","author":"Skalsky","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0480","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","article-title":"Cellular responses to viral infection in humans: lessons from Epstein-Barr virus","volume":"25","author":"Hislop","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2010.08.019_b0485","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.4049\/jimmunol.165.12.7078","article-title":"The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1","volume":"165","author":"Blake","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2010.08.019_b0490","doi-asserted-by":"crossref","first-page":"8649","DOI":"10.1128\/JVI.75.18.8649-8659.2001","article-title":"Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses","volume":"75","author":"Leen","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0495","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1084\/jem.191.10.1649","article-title":"Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1","volume":"191","author":"Munz","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2010.08.019_b0500","first-page":"6219","article-title":"Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin\u2019s disease patients: implications for a T-cell-based therapy","volume":"61","author":"Chapman","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2010.08.019_b0505","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4049\/jimmunol.165.1.573","article-title":"CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells","volume":"165","author":"Lee","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2010.08.019_b0510","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00262-007-0427-8","article-title":"CD4 and CD8 T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patients","volume":"57","author":"Lin","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2010.08.019_b0515","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1073\/pnas.0813320106","article-title":"Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma","volume":"106","author":"Fogg","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2010.08.019_b0520","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/ijc.23845","article-title":"Patients with Epstein Barr virus-positive lymphomas have decreased CD4(+) T-cell responses to the viral nuclear antigen 1","volume":"123","author":"Heller","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2010.08.019_b0525","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/ijc.24014","article-title":"Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-gamma T cell responses","volume":"124","author":"Moormann","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2010.08.019_b0530","doi-asserted-by":"crossref","first-page":"7935","DOI":"10.1158\/0008-5472.CAN-09-0828","article-title":"EBV-induced human CD8+ NKT cells suppress tumorigenesis by EBV-associated malignancies","volume":"69","author":"Yuling","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2010.08.019_b0535","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ijc.10326","article-title":"Peripheral gamma delta T-cell deficit in nasopharyngeal carcinoma","volume":"99","author":"Zheng","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2010.08.019_b0540","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00262-008-0629-8","article-title":"Phenotypic and functional alterations of Vgamma2Vdelta2 T cell subsets in patients with active nasopharyngeal carcinoma","volume":"58","author":"Puan","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2010.08.019_b0545","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1128\/JVI.73.7.6136-6140.1999","article-title":"Identification of human herpesvirus 8-specific cytotoxic T-cell responses","volume":"73","author":"Osman","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0550","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1086\/322003","article-title":"Definition of an optimal cytotoxic T lymphocyte epitope in the latently expressed Kaposi\u2019s sarcoma-associated herpesvirus kaposin protein","volume":"184","author":"Brander","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2010.08.019_b0555","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1128\/JVI.02509-06","article-title":"Lytic and latent antigens of the human gammaherpesviruses Kaposi\u2019s sarcoma-associated herpesvirus and Epstein-Barr virus induce T-cell responses with similar functional properties and memory phenotypes","volume":"81","author":"Bihl","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b1095","doi-asserted-by":"crossref","first-page":"e5890","DOI":"10.1371\/journal.pone.0005890","article-title":"The CD8 and CD4 T-cell response against Kaposi\u2019s sarcoma-associated herpesvirus is skewed towards early and late lytic antigens","volume":"4","author":"Robey","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2010.08.019_b0565","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00002030-200402200-00015","article-title":"Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia","volume":"18","author":"Bourboulia","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2010.08.019_b0570","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1002\/1521-4141(2002010)32:10<2711::AID-IMMU2711>3.0.CO;2-3","article-title":"NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi\u2019s sarcoma","volume":"32","author":"Sirianni","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.canlet.2010.08.019_b0575","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/507648","article-title":"Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma","volume":"194","author":"Guihot","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2010.08.019_b0580","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0140-6736(90)90001-L","article-title":"Kaposi\u2019s sarcoma among persons with AIDS: a sexually transmitted infection?","volume":"335","author":"Beral","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2010.08.019_b0585","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00002030-199602000-00007","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus infection prior to onset of Kaposi\u2019s sarcoma","volume":"10","author":"Moore","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2010.08.019_b0590","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1086\/341088","article-title":"Prognostic value of quantitative Kaposi sarcoma-associated herpesvirus load in posttransplantation Kaposi sarcoma","volume":"186","author":"Pellet","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2010.08.019_b0595","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/sj.bjc.6601113","article-title":"Infection with Kaposi\u2019s sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi\u2019s sarcoma in Uganda","volume":"89","author":"Newton","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2010.08.019_b0600","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ijc.10818","article-title":"Risk factors for Kaposi\u2019s sarcoma: a case-control study of HIV-seronegative people in Uganda","volume":"103","author":"Ziegler","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2010.08.019_b0605","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00007890-197901000-00003","article-title":"Kaposi\u2019s sarcoma in organ transplant recipients: report of 20 cases","volume":"27","author":"Penn","year":"1979","journal-title":"Transplantation"},{"key":"10.1016\/j.canlet.2010.08.019_b0610","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1097\/QAD.0b013e3283300a91","article-title":"Cellular immune responses and disease control in acute AIDS-associated Kaposi\u2019s sarcoma","volume":"23","author":"Bihl","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2010.08.019_b0615","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1349-7006.2006.00319.x","article-title":"Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells","volume":"97","author":"Dewan","year":"2006","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2010.08.019_b0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2007.06.012","article-title":"Reflections on the interpretation of heterogeneity and strain differences based on very limited PCR sequence data from Kaposi\u2019s sarcoma-associated herpesvirus genomes","volume":"40","author":"Zong","year":"2007","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0625","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.4049\/jimmunol.180.5.3417","article-title":"Gamma delta+ T cells involvement in viral immune control of chronic human herpesvirus 8 infection","volume":"180","author":"Barcy","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2010.08.019_b0630","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200011093431905","article-title":"Bone marrow failure associated with human herpesvirus 8 infection after transplantation","volume":"343","author":"Luppi","year":"2000","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.canlet.2010.08.019_b0635","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1056\/NEJMc070508","article-title":"HIV-associated Kaposi\u2019s sarcoma with a high CD4 count and a low viral load","volume":"357","author":"Maurer","year":"2007","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.canlet.2010.08.019_b0640","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/QAD.0b013e3282f4de5d","article-title":"AIDS-associated Kaposi\u2019s sarcoma associated with a low viral load and a high CD4 cell count","volume":"22","author":"Stebbing","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2010.08.019_b0645","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/QAD.0b013e3283031a8a","article-title":"Kaposi\u2019s sarcoma in HIV-negative men having sex with men","volume":"22","author":"Lanternier","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2010.08.019_b0650","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1182\/blood-2007-05-085159","article-title":"PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma","volume":"111","author":"Yamamoto","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b0655","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1399-0039.2008.01005.x","article-title":"HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin\u2019s lymphoma","volume":"71","author":"Diepstra","year":"2008","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.canlet.2010.08.019_b0660","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1002\/ijc.22334","article-title":"Association of immunoescape mechanisms with Epstein-Barr virus infection in nasopharyngeal carcinoma","volume":"120","author":"Ogino","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2010.08.019_b0665","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1073\/pnas.0400765101","article-title":"Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin\u2019s lymphoma cells from autonomous Fas-mediated death","volume":"101","author":"Dutton","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2010.08.019_b0670","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0046-8177(93)90034-E","article-title":"Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin\u2019s Reed\u2013Sternberg cells and by reactive T lymphocytes in Hodgkin\u2019s disease","volume":"24","author":"Hsu","year":"1993","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.canlet.2010.08.019_b0675","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/blood.V87.7.2918.bloodjournal8772918","article-title":"Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin\u2019s disease","volume":"87","author":"Herbst","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b0680","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1182\/blood-2007-01-066100","article-title":"Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma","volume":"110","author":"Gandhi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b0685","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1182\/blood-2008-02-142596","article-title":"Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells","volume":"113","author":"Klibi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b0690","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2003-07-2594","article-title":"Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma","volume":"103","author":"Marshall","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b0695","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.bjc.6603580","article-title":"Increase in circulating Foxp3+CD4+CD25(high) regulatory T cells in nasopharyngeal carcinoma patients","volume":"96","author":"Lau","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2010.08.019_b1100","doi-asserted-by":"crossref","first-page":"e1122","DOI":"10.1371\/journal.pone.0001122","article-title":"Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy","volume":"2","author":"Li","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2010.08.019_b0705","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2353\/ajpath.2008.070845","article-title":"Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin\u2019s lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells","volume":"173","author":"Baumforth","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2010.08.019_b0710","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4049\/jimmunol.165.2.663","article-title":"Direct immunosuppressive effects of EBV-encoded latent membrane protein 1","volume":"165","author":"Dukers","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2010.08.019_b0715","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1099\/vir.0.18944-0","article-title":"Localization of the Epstein-Barr virus protein LMP 1 to exosomes","volume":"84","author":"Flanagan","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0720","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1128\/JVI.78.5.2591-2596.2004","article-title":"Inflammatory cytokines inhibit Kaposi\u2019s sarcoma-associated herpesvirus lytic gene transcription in in vitro-infected endothelial cells","volume":"78","author":"Milligan","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b1105","first-page":"240","article-title":"Human immunodeficiency virus-associated oral Kaposi\u2019s sarcoma. A heterogeneous cell population dominated by spindle-shaped endothelial cells","volume":"143","author":"Regezi","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2010.08.019_b0730","doi-asserted-by":"crossref","first-page":"7963","DOI":"10.1128\/JVI.71.10.7963-7968.1997","article-title":"Monocytes in Kaposi\u2019s sarcoma lesions are productively infected by human herpesvirus 8","volume":"71","author":"Blasig","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0735","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-0560.1996.tb01436.x","article-title":"Macrophages and vascular adhesion molecules in oral Kaposi\u2019s sarcoma","volume":"23","author":"MacPhail","year":"1996","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.canlet.2010.08.019_b1110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0092-8674(00)80398-0","article-title":"KSHV and Kaposi\u2019s sarcoma: the end of the beginning?","volume":"91","author":"Ganem","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2010.08.019_b1115","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1084\/jem.191.3.417","article-title":"Viral G protein-coupled receptor and Kaposi\u2019s sarcoma: a model of paracrine neoplasia?","volume":"191","author":"Cesarman","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2010.08.019_b0750","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1073\/pnas.87.11.4068","article-title":"AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6","volume":"87","author":"Miles","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2010.08.019_b0755","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1128\/JVI.02089-06","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1","volume":"81","author":"Ye","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0760","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1128\/JVI.00873-07","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications","volume":"82","author":"Sivakumar","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0765","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1182\/blood-2003-12-4436","article-title":"The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia","volume":"104","author":"Montaner","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b0770","first-page":"5002","article-title":"Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium","volume":"59","author":"Olumi","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2010.08.019_b0775","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/bjc.1993.453","article-title":"Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts","volume":"68","author":"Noel","year":"1993","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2010.08.019_b0780","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/sj.bjc.6604662","article-title":"The role of endothelial-to-mesenchymal transition in cancer progression","volume":"99","author":"Potenta","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2010.08.019_b0785","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1101\/gad.553410","article-title":"KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming","volume":"24","author":"Hansen","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2010.08.019_b1120","doi-asserted-by":"crossref","first-page":"e7965","DOI":"10.1371\/journal.pone.0007965","article-title":"Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model","volume":"4","author":"Liao","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2010.08.019_b0795","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1189\/jlb.0409251","article-title":"Pivotal advance: Kaposi\u2019s sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes","volume":"87","author":"Qin","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.canlet.2010.08.019_b0800","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1097\/01.aids.0000189849.75699.46","article-title":"Inhibition of neutrophil function by the Kaposi\u2019s sarcoma-associated herpesvirus vOX2 protein","volume":"19","author":"Rezaee","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2010.08.019_b0805","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1158\/0008-5472.CAN-03-3835","article-title":"The tumor microenvironment controls primary effusion lymphoma growth in vivo","volume":"64","author":"Staudt","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2010.08.019_b0810","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1182\/blood.V96.4.1599","article-title":"Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions","volume":"96","author":"Aoki","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b0815","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1182\/blood.V94.8.2871","article-title":"Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi\u2019s sarcoma herpesvirus-associated infected primary effusion lymphoma cells","volume":"94","author":"Jones","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b0820","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1182\/blood.V96.6.2069","article-title":"High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients","volume":"96","author":"Oksenhendler","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b0825","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood.V96.7.2562","article-title":"An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus","volume":"96","author":"Foster","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b1125","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1086\/501470","article-title":"Sarcoma genetics working host immunogenetics and control of human herpesvirus-8 infection","volume":"193","author":"Brown","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2010.08.019_b0835","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1158\/1055-9965.EPI-05-0791","article-title":"Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity","volume":"15","author":"Brown","year":"2006","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.canlet.2010.08.019_b0840","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.278.5336.290","article-title":"Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines","volume":"278","author":"Boshoff","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.canlet.2010.08.019_b0845","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1002\/1521-4141(200108)31:8<2458::AID-IMMU2458>3.0.CO;2-L","article-title":"Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II","volume":"31","author":"Weber","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.canlet.2010.08.019_b0850","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood.V95.4.1151.004k37_1151_1157","article-title":"KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells","volume":"95","author":"Stine","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b0855","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tim.2008.12.001","article-title":"Modulation of the immune system by Kaposi\u2019s sarcoma-associated herpesvirus","volume":"17","author":"Areste","year":"2009","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.canlet.2010.08.019_b0860","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1073\/pnas.0913586107","article-title":"The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro","volume":"107","author":"Arbuckle","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2010.08.019_b0865","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1099-1654(200003\/04)10:2<83::AID-RMV262>3.0.CO;2-T","article-title":"EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus","volume":"10","author":"Leight","year":"2000","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0870","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1126\/science.284.5414.641","article-title":"Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen","volume":"284","author":"Ballestas","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.canlet.2010.08.019_b0875","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/375685a0","article-title":"Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1","volume":"375","author":"Levitskaya","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2010.08.019_b0880","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1084\/jem.20040121","article-title":"CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1","volume":"199","author":"Lee","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2010.08.019_b0885","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1084\/jem.20040191","article-title":"Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1","volume":"199","author":"Tellam","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2010.08.019_b0890","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.20031219","article-title":"Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes","volume":"199","author":"Voo","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2010.08.019_b0895","doi-asserted-by":"crossref","first-page":"9319","DOI":"10.1073\/pnas.0801968105","article-title":"Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition","volume":"105","author":"Tellam","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2010.08.019_b0900","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/JVI.01369-08","article-title":"mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1","volume":"83","author":"Apcher","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0905","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1086\/432103","article-title":"Impact of Kaposi sarcoma-associated herpesvirus (KSHV) burden and HIV coinfection on the detection of T cell responses to KSHV ORF73 and ORF65 proteins","volume":"192","author":"Woodberry","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2010.08.019_b0910","doi-asserted-by":"crossref","first-page":"8225","DOI":"10.1128\/JVI.00411-07","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing","volume":"81","author":"Kwun","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0915","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.molimm.2006.05.012","article-title":"In cis inhibition of antigen processing by the latency-associated nuclear antigen I of Kaposi sarcoma herpes virus","volume":"44","author":"Zaldumbide","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.canlet.2010.08.019_b0920","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1016\/j.molimm.2007.03.005","article-title":"The nested open reading frame in the Epstein-Barr virus nuclear antigen-1 mRNA encodes a protein capable of inhibiting antigen presentation in cis","volume":"44","author":"Ossevoort","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.canlet.2010.08.019_b0925","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2010.08.019_b0930","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4161\/auto.5.7.9163","article-title":"Nuclear membrane-derived autophagy, a novel process that participates in the presentation of endogenous viral antigens during HSV-1 infection","volume":"5","author":"English","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2010.08.019_b0935","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.1104904","article-title":"Endogenous MHC class II processing of a viral nuclear antigen after autophagy","volume":"307","author":"Paludan","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.canlet.2010.08.019_b0940","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2005.07.002","article-title":"Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy","volume":"122","author":"Pattingre","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2010.08.019_b1130","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1371\/journal.ppat.0030174","article-title":"A novel inhibitory mechanism of mitochondrion-dependent apoptosis by a herpesviral protein","volume":"3","author":"Feng","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.canlet.2010.08.019_b0950","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1038\/sj.onc.1210946","article-title":"The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy","volume":"27","author":"Lee","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2010.08.019_b0955","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1073\/pnas.0909448107","article-title":"Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display","volume":"107","author":"Leung","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2010.08.019_b0960","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1128\/JVI.79.8.4896-4907.2005","article-title":"CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines","volume":"79","author":"Long","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b0965","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/intimm\/9.10.1537","article-title":"Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processing","volume":"9","author":"Khanna","year":"1997","journal-title":"Int. Immunol."},{"key":"10.1016\/j.canlet.2010.08.019_b0970","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1002\/eji.200324794","article-title":"Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells","volume":"34","author":"Mautner","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.canlet.2010.08.019_b0975","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1073\/pnas.84.13.4567","article-title":"Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines","volume":"84","author":"Masucci","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2010.08.019_b0980","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1182\/blood.V92.7.2477","article-title":"Analysis of major histocompatibility complex class I, TAP expression, and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin\u2019s disease","volume":"92","author":"Murray","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b0985","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1182\/blood.V92.3.1020","article-title":"Antigen presenting phenotype of Hodgkin Reed\u2013Sternberg cells: analysis of the HLA class I processing pathway and the effects of interleukin-10 on epstein-barr virus-specific cytotoxic T-cell recognition","volume":"92","author":"Lee","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b0990","first-page":"310","article-title":"Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells","volume":"58","author":"Khanna","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2010.08.019_b0995","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.4049\/jimmunol.169.3.1593","article-title":"Epstein-Barr nuclear antigen 1-specific CD4(+) Th1 cells kill Burkitt\u2019s lymphoma cells","volume":"169","author":"Paludan","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2010.08.019_b1000","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.4049\/jimmunol.180.3.1643","article-title":"EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell lines","volume":"180","author":"Haigh","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2010.08.019_b1005","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1158\/0008-5472.CAN-07-3212","article-title":"Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells","volume":"68","author":"Kobayashi","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2010.08.019_b1010","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1128\/JVI.78.2.768-778.2004","article-title":"Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+ and CD8+ T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma","volume":"78","author":"Taylor","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b1015","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.4049\/jimmunol.165.4.2077","article-title":"Impaired CTL recognition of cells latently infected with Kaposi\u2019s sarcoma-associated herpes virus","volume":"165","author":"Brander","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2010.08.019_b1020","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1128\/JVI.01946-07","article-title":"The DNase of gammaherpesviruses impairs recognition by virus-specific CD8+ T cells through an additional host shutoff function","volume":"82","author":"Zuo","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b1025","doi-asserted-by":"crossref","first-page":"9669","DOI":"10.1128\/JVI.77.17.9669-9684.2003","article-title":"Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following De Novo infection of endothelial cells with Kaposi\u2019s sarcoma-associated herpesvirus","volume":"77","author":"Tomescu","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b1030","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1128\/JVI.74.11.5300-5309.2000","article-title":"Downregulation of major histocompatibility complex class I molecules by Kaposi\u2019s sarcoma-associated herpesvirus K3 and K5 proteins","volume":"74","author":"Ishido","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b1035","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1083\/jcb.200111010","article-title":"A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition","volume":"155","author":"Coscoy","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2010.08.019_b1040","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1128\/JVI.01961-06","article-title":"Downregulation of gamma interferon receptor 1 by Kaposi\u2019s sarcoma-associated herpesvirus K3 and K5","volume":"81","author":"Li","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b1045","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1182\/blood-2006-05-024034","article-title":"Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells","volume":"109","author":"Lagos","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.08.019_b1050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF01541091","article-title":"No significant association between HLA antigens and classic Kaposi sarcoma: molecular analysis of 49 Jewish patients","volume":"15","author":"Strichman-Almashanu","year":"1995","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.canlet.2010.08.019_b1055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00002030-200401230-00008","article-title":"Amino acid residue at position 13 in HLA-DR beta chain plays a critical role in the development of Kaposi\u2019s sarcoma in AIDS patients","volume":"18","author":"Gaya","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2010.08.019_b1060","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/jmv.20361","article-title":"HLA-B, -DRB1\/3\/4\/5, and -DQB1 gene polymorphisms in human immunodeficiency virus-related Kaposi\u2019s sarcoma","volume":"76","author":"Dorak","year":"2005","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.canlet.2010.08.019_b1065","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1086\/511827","article-title":"Influence of HLA alleles on shedding of Kaposi sarcoma-associated herpesvirus in saliva in an African population","volume":"195","author":"Alkharsah","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2010.08.019_b1070","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00262-006-0225-8","article-title":"Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients","volume":"56","author":"Ghiringhelli","year":"2007","journal-title":"Cancer Immunol. Immunother."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383511001595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383511001595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T09:00:30Z","timestamp":1592470830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383511001595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":214,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0304383511001595"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2010.08.019","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}